click below
click below
Normal Size Small Size show me how
ENDOCRINE 3
| Pharmacologic Category | Generic | Brand | Classification | Common Indications | Essential Knowledge |
|---|---|---|---|---|---|
| Androgen | testosterone gel (topical) | AndroGel, Fortesta, Vogelxo | CS-III | Male hypogonadism | Key Side Effects: contact dermatitis, acne, increased prostate specific antigen (PSA), emotional lability, HTN BBW: secondary exposure may result in virilization CI in males with breast or prostate cancer and pregnant women; apply in the morning |
| Bisphosphonate | alendronate (PO) | Fosamax | Osteoporosis | Key Side Effects: dyspepsia, gastroesophageal reflux disease, hypocalcemia, atypical fractures, osteonecrosis of the jaw Other Notes: CI in patients with hypocalcemia or abnormalities of the esophagus; administer ≥30 minutes before food or drink | |
| Vitamin D analog | cholecalciferol (vitamin D3) (PO) | OTC | Dietary supplement, osteoporosis prevention | Key Side Effect: vitamin D toxicity (nausea, vomiting, loss of appetite, constipation, confusion, weakness) Other Note: CI with hypercalcemia | |
| Phosphodiesterase-5 enzyme (PDE5) inhibitor | sildenafil (PO) | Viagra, Revatio | ED, PAH | Key Side Effects: priapism, headache, flushing, visual disturbance, dyspepsia, back pain (mostly with tadalafil), hearing or vision loss (rare) Other Notes: CI with concomitant use of nitrates (may cause severe hypotension) | |
| Phosphodiesterase-5 enzyme (PDE5) inhibitor | tadalafil (PO) | Cialis, Adcirca | ED, BPH, PAH | Key Side Effects: priapism, headache, flushing, visual disturbance, dyspepsia, back pain (mostly with tadalafil), hearing or vision loss (rare) Other Notes: CI with concomitant use of nitrates (may cause severe hypotension) | |
| Thyroid product | levothyroxine (PO, IV) | Synthroid, Levoxyl, Unithroid | Hypothyroidism | Key Side Effects: weight loss, palpitations, diarrhea, insomnia, heat intolerance US Boxed Warnings: not intended for use for weight loss Other Notes: narrow therapeutic index drug (therapeutic monitoring is recommended); | |
| Thyroid product | thyroid, desiccated (PO) | Armour Thyroid | Hypothyroidism | Key Side Effects: weight loss, palpitations, diarrhea, insomnia, heat intolerance US Boxed Warnings: not intended for use for weight loss Other Notes: narrow therapeutic index drug (therapeutic monitoring is recommended); | |
| CNS stimulant, anorexiant | phentermine (PO) | Adipex-P | Obesity | Key Side Effects: tachycardia, hypertension, nausea, dizziness, xerostomia, agitation Notes: only approved for short-term use; CI in those with a history of CV disease or drug abuse, pregnancy, hyperthyroidism, or within 14 days of MAOI therapy |